Glutamate-induced increases in transglutaminase activity in primary cultures of astroglial cells

Glutamate exposure of astroglial cells caused ligand-gated channel receptor activation, associated with excitotoxic cell response. We investigated the effects of 24 h glutamate exposure on transglutaminase in astrocytes primary cultures at 7, 14, and 21 days in vitro (DIV). Increases in enzyme activity were observed as a function of cell differentiation stage in glutamate-treated cultures. These effects were significantly reduced when GYKI 52466, an AMPA/KA receptors inhibitor, was added to the culture medium prior to incubation with glutamate. Microscopy observation on transglutaminase-mediated, fluorescent dansylcadaverine incorporation in living cells was consistent with these results. Western blotting analysis with monoclonal antibody showed that glutamate also up-regulated tissue transglutaminase expression, which reached the highest values in 14 DIV cultures. Confocal laser scanning microscopy analysis of immunostained astroglial cells showed a mainly cytoplasmic localisation of the enzyme both in control and treated cultures; nevertheless, counterstaining with the nuclear dye acridine orange demonstrated the presence of tissue transglutaminase also into the nucleus of glutamate-exposed and 21 DIV cells. The increases in enzyme expression and localisation in the nucleus of glutamate-treated astroglial cells may be part of biochemical alterations induced by excitotoxic stimulus.

[1]  David R. Brown Dependence of Neurones on Astrocytes in a Coculture System Renders Neurones Sensitive to Transforming Growth Factor \gb\1‐Induced Glutamate Toxicity , 1999, Journal of neurochemistry.

[2]  D. Allan Butterfield,et al.  Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins , 2001, Mechanisms of Ageing and Development.

[3]  B. Hamprecht,et al.  Cellular Localization and Regulation of Glutamine Synthetase in Primary Cultures of Brain Cells from Newborn Mice , 1981, Journal of neurochemistry.

[4]  O. Eizenberg,et al.  Expression of GTP-dependent and GTP-independent Tissue-type Transglutaminase in Cytokine-treated Rat Brain Astrocytes* , 1997, The Journal of Biological Chemistry.

[5]  B. Clark,et al.  Currents evoked in Bergmann glial cells by parallel fibre stimulation in rat cerebellar slices , 1997, The Journal of physiology.

[6]  J. Blass,et al.  Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases. , 1998, Archives of biochemistry and biophysics.

[7]  G. Johnson,et al.  Tissue transglutaminase: a possible role in neurodegenerative diseases , 2000, Progress in Neurobiology.

[8]  John M. Lee,et al.  Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease , 2002, Neurochemistry International.

[9]  K. Santacruz,et al.  Injury‐induced ‘switch’ from GTP‐regulated to novel GTP‐independent isoform of tissue transglutaminase in the rat spinal cord , 2002, Journal of neurochemistry.

[10]  F. Conti,et al.  Expression and functional analysis of glutamate receptors in glial cells. , 1999, Advances in experimental medicine and biology.

[11]  G. Melino,et al.  ‘Tissue’ transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease , 2002, Cell Death and Differentiation.

[12]  L. Kaczmarek,et al.  Induction of Primary Response Genes by Excitatory Amino Acid Receptor Agonists in Primary Astroglial Cultures , 1993, Journal of neurochemistry.

[13]  K. McCarthy,et al.  Hippocampal Astrocytes In Situ Respond to Glutamate Released from Synaptic Terminals , 1996, The Journal of Neuroscience.

[14]  V. Gentile,et al.  Tissue transglutaminase and coeliac disease pathogenesis: potential molecular mechanisms for other human diseases , 2002, Neurochemistry International.

[15]  D. Cassarino,et al.  An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration , 1999, Brain Research Reviews.

[16]  G. Johnson,et al.  Tissue transglutaminase differentially modulates apoptosis in a stimuli‐dependent manner , 2002, Journal of neurochemistry.

[17]  A. Charles,et al.  Intercellular signaling in glial cells: Calcium waves and oscillations in response to mechanical stimulation and glutamate , 1991, Neuron.

[18]  B. Ahlemeyer,et al.  Increase in glutamate‐induced neurotoxicity by activated astrocytes involves stimulation of protein kinase C , 2002, Journal of neurochemistry.

[19]  S. Hunt,et al.  Regulation of gene expression in astrocytes by excitatory amino acids. , 1992, Brain research. Molecular brain research.

[20]  V. Gallo,et al.  Excitatory amino acid receptors in glia: Different subtypes for distinct functions? , 1995, Journal of neuroscience research.

[21]  G. Johnson,et al.  Distinct Nuclear Localization and Activity of Tissue Transglutaminase* , 1998, The Journal of Biological Chemistry.

[22]  R. Ientile,et al.  NMDA-evoked excitotoxicity increases tissue transglutaminase in cerebellar granule cells , 2002, Neuroscience.

[23]  V. Gallo,et al.  A role for glutamate and its receptors in the regulation of oligodendrocyte development in cerebellar tissue slices. , 1998, Development.

[24]  P. Matarrese,et al.  Transglutaminase overexpression sensitizes neuronal cell lines to apoptosis by increasing mitochondrial membrane potential and cellular oxidative stress , 2002, Journal of neurochemistry.

[25]  W. Walz Role of glial cells in the regulation of the brain ion microenvironment , 1989, Progress in Neurobiology.

[26]  I. Black,et al.  Expression and regulation of catecholaminergic traits in primary sensory neurons: relationship to target innervation in vivo , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[27]  V. Gallo,et al.  Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K+ channel block , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[28]  Soo-Youl Kim,et al.  Differential Expression of Multiple Transglutaminases in Human Brain , 1999, The Journal of Biological Chemistry.

[29]  S. Mahoney,et al.  Transglutaminase C in cerebellar granule neurons: Regulation and localization of substrate cross-linking , 1995, Neuroscience.

[30]  Tami L. Bach,et al.  Colocalization of tissue transglutaminase and stress fibers in human vascular smooth muscle cells and human umbilical vein endothelial cells. , 1997, Experimental cell research.

[31]  K. Mehta,et al.  Tissue transglutaminase: an enzyme with a split personality. , 1999, The international journal of biochemistry & cell biology.

[32]  K. Santacruz,et al.  Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration , 2002, Neurochemistry International.

[33]  W. Strittmatter,et al.  Pathogenesis of Inclusion Bodies in (CAG)n/Qn‐Expansion Diseases with Special Reference to the Role of Tissue Transglutaminase and to Selective Vulnerability , 1999, Journal of neurochemistry.

[34]  J. Blass,et al.  Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG) n /Q n -expansion diseases? , 2002, Neurochemistry International.